Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Justin G. Horowitz"'
Autor:
Paul J. Shaughnessy, Brittney A Ramirez, Justin G. Horowitz, Grace C. Lee, Carole Elledge, Gerard W Gawrys
Publikováno v:
Transplant Infectious Disease. 23
BACKGROUND Autologous hematopoietic stem cell transplantation (HSCT) recipients are at increased risk of developing life-threatening infections. There is discordance in published recommendations for timing of pre- and post-transplant antimicrobial pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b32eede5e0df1c31361f2bb73f96d1ac
https://doi.org/10.1111/tid.13689
https://doi.org/10.1111/tid.13689
Autor:
Jackie Kemp, Gerard W. Gawrys, Jose C. Cruz, Paul J. Shaughnessy, Brittney Ramirez, Justin G. Horowitz, Grace C. Lee
Publikováno v:
Biology of Blood and Marrow Transplantation. 26:S317
Background Hematopoietic stem cell transplantation (HSCT) recipients often develop profound neutropenia and are ultimately at an increased risk of developing life-threatening infections peri-engraftment. There is discordance in the current guidelines
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dd8ce4425bf5507fa8c7fd9bce721b10
https://doi.org/10.1016/j.bbmt.2019.12.338
https://doi.org/10.1016/j.bbmt.2019.12.338
Autor:
Jackie Kemp, Carole Elledge, C. B. Jackson, Cesar O. Freytes, Justin G. Horowitz, Paul J. Shaughnessy, Jose C. Cruz, Gerard W. Gawrys, Brenda Astorga
Publikováno v:
Biology of Blood and Marrow Transplantation. 26:S329
Background More than approximately 80% of hematopoietic stem cell transplant (HSCT) patients develop neutropenic fever warranting anti-Pseudomonal therapy (APT). Although Pseudomonas is not the most common pathogen causing febrile neutropenia, APT is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8eeccaab27a1f93b32f6a1161b8f8fe4
https://doi.org/10.1016/j.bbmt.2019.12.354
https://doi.org/10.1016/j.bbmt.2019.12.354
Autor:
Justin G. Horowitz, Jose M. Magraner, Paul J. Shaughnessy, Mohammed M. Elayan, Carlos Bachier
Publikováno v:
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 21(11)
There are limited data available supporting the use of the recombinant granulocyte colony-stimulating factor (G-CSF), tbo-filgrastim, rather than traditionally used filgrastim to mobilize peripheral blood stem cells (PBSC) or to accelerate engraftmen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d1efbd6fee7796365bd20247f2ac461
https://pubmed.ncbi.nlm.nih.gov/26386319
https://pubmed.ncbi.nlm.nih.gov/26386319